Taiwan FDA registration bfcd81256ef36ca9ebc3608f7d74d9e1
Otri Plus Injection (Pre-filled Syringe)
TW: 利敏捷關節腔注射劑
Taiwan·Risk Class 3·MD·Yoo Young Pharmaceutical Co., Ltd.·Registered Mar 26, 2019 – Mar 26, 2024ExpiredRegistration details
- Analysis ID
- bfcd81256ef36ca9ebc3608f7d74d9e1
- License Form
- Ministry of Health Medical Device Import No. 032356
- Customs Code
- DHA05603235607
Company information
- Manufacturer
- Yoo Young Pharmaceutical Co., Ltd.
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- HIPPOCRATES PHARMA CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- N Orthopedic devices
- Product Type (Level 2)
- N0003 Hyaluronic acid implants for the joint cavity
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Mar 26, 2019
- Expiry Date
- Mar 26, 2024
About this record
Access comprehensive regulatory information for Otri Plus Injection (Pre-filled Syringe) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number bfcd81256ef36ca9ebc3608f7d74d9e1 and manufactured by Yoo Young Pharmaceutical Co., Ltd.. The authorized representative in Taiwan is HIPPOCRATES PHARMA CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices